Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
XDYSYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.18.4SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
KP.4.1.3SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
KS.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
MM.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.48.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
KP.4.2.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
KP.3.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
MC.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
LB.1.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
LP.1.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.50.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13443.5Singapore
MH.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
LB.1.3.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
LB.1.3.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
KP.3.4SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
LB.1.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
KP.2.6SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
MA.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
KP.3.1.4SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
LB.1.8SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
XBB.1.5.81SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
CH.1.1.20SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBL.3.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBB.2.4SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBB.1.28.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
GA.6.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBB.1.16.14SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
EG.5.1.5SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
FL.28SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
FL.20.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBB.1.5.110SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
BA.2.86.3SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
GN.4SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBB.8.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
HB.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
EG.10.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBB.1.5.89SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
HR.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
HP.1.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
GW.4SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
GS.4SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XCF.3SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
FL.34SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
JC.5SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBB.1.5.105SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBB.1.9.4SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
GJ.4SYoung-STATACATGTCTCTGGGACCA20452176321782F-19280Singapore
GK.1.4SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
FY.4.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used